产品介绍
Product Description
Biochem/physiol Actions
Novel antidepressant; mixed 5-HT2A serotonin receptor antagonist/serotonin uptake inhibitor.
Features and Benefits
This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
技术参数
Specifications
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | solid |
| storage condition | desiccated |
| color | white |
| solubility | DMSO: ≥10 mg/mL,H2O: insoluble |
| originator | Bristol-Myers Squibb |
| SMILES string | O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C(CC)N1CCOC4=CC=CC=C4.Cl |
| InChI | 1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H |
| InChI key | DYCKFEBIOUQECE-UHFFFAOYSA-N |
| Gene Information | human ... HTR2A(3356), HTR2C(3358), SLC6A2(6530), SLC6A4(6532) |
